Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care
Season 4, Episode 20, Dec 15, 2023, 03:45 PM
In this episode of Targeted Talks, Aaron Lisberg, MD, discusses results from the phase 3 TROPION-Lung01 study of datopotamab c in advanced or metastatic non–small cell lung cancer.
In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.